MyLife Diabetes Care announced that its transition into an independent company has now been formally completed.

LifeScan CEO Valerie Asbury said on social media today that she is retiring from the glucose management technology developer.

The site, in Lehigh Valley, will serve as the company’s newest injectable medicine and device manufacturing facility. Indianapolis-based Lilly plans to produce next-generation weight-loss therapies ...

Senseonics (NYSE:SENS) announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark ...

Insulin patch pump maker ViCentra announced today that it appointed Reman McDonagh as its VP, global marketing.

Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) ...

CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate the development ...

Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR ...

MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

A rendering of the KnowU non-invasive glucose monitor. [Image courtesy of Know Labs] Know Labs (NYSE:KNW) today unveiled KnowU, its wearable, non-invasive continuous glucose monitor (CGM) system.

Left: the Abbott FreeStyle Libre 3 CGM. Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing ...